Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -28.88% of over the last 5 years
The company has declared negative results for the last 11 consecutive quarters
With ROCE of 1.8, it has a Expensive valuation with a 1.4 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 561 Cr (Micro Cap)
NA (Loss Making)
39
0.32%
0.29
0.82%
1.40
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Falls to 52-Week Low of Rs 270 as Sell-Off Deepens
A sharp decline has pushed Chemfab Alkalis Ltd to a fresh 52-week low of Rs 270 on 1 Apr 2026, marking a significant 70% drop from its 52-week high of Rs 900. This fall comes despite a brief intraday recovery, underscoring persistent selling pressure on the stock.
Read full news article
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 01 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Chemfab Alkalis Limited - Other General Purpose
04-Nov-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange that Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities
Chemfab Alkalis Limited - Outcome of Board Meeting
31-Oct-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange regarding Board meeting held on October 30, 2019.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.08%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.56%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024







